WT1 and central nervous system cancer: Wilms’ tumor 1 in glioma-derived EVs serves as a potent promoter of tumor progression by inhibiting microglial expression of the Thbs1 gene and acts as an anti-angiogenic factor, which may lead to enhanced angiogenesis in glioma [154].